Preferred Label : antigens, CD34;
MeSH definition : Glycoproteins found on immature hematopoietic cells and endothelial cells. They are
the only molecules to date whose expression within the blood system is restricted
to a small number of progenitor cells in the bone marrow.;
MeSH synonym : cd34 antigen; antigen, cd34; cd34 antigens;
MeSH annotation : differentiation antigens;
Wikipedia link : https://en.wikipedia.org/wiki/Antigens, cd34;
Is substance : O;
Origin ID : D018952;
UMLS CUI : C0054953;
Allowable qualifiers
- Automatic exact mappings (from CISMeF team)
- Indexing information
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
Glycoproteins found on immature hematopoietic cells and endothelial cells. They are
the only molecules to date whose expression within the blood system is restricted
to a small number of progenitor cells in the bone marrow.
https://www.has-sante.fr/jcms/p_3149186/fr/zynteglo
2020
false
false
false
France
treatment outcome
betibeglogene autotemcel
infusions, intravenous
genetic therapy
orphan drug production
hematopoietic stem cells
beta-Thalassemia
beta-Thalassemia
hematopoietic stem cell transplantation
beta(A-T87Q) globin
antigens, CD34
betibeglogene autotemcel
evaluation of the transparency committee
beta-Globins
---
https://www.has-sante.fr/jcms/p_3165706/fr/zynteglo
2020
false
false
false
France
beta-Thalassemia
genetic therapy
hematopoietic stem cells
hematopoietic stem cell transplantation
antigens, CD34
beta(A-T87Q) globin
infusions, intravenous
insurance, health, reimbursement
transplantation, autologous
Betibeglogene Autotemcel
betibeglogene autotemcel
betibeglogene autotemcel
evaluation of the transparency committee
beta-Globins
---
https://www.has-sante.fr/jcms/p_3101057/fr/combo-plus-stent
2019
France
health technology assessment
extracellular matrix
templates, genetic
pharmacology
monoclonal antibody
Monoclonal antibodies
pharmacologist
stents
sirolimus
Drug-Eluting stents
antibodies, monoclonal
Monoclonal antibodies
antibodies, anti-idiotypic
antigens, CD34
stents
---
https://www.ema.europa.eu/en/medicines/human/EPAR/zynteglo
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
beta(A-T87Q) globin
transplantation, autologous
adolescent
adult
beta-Thalassemia
antigens, CD34
orphan drug production
infusions, intravenous
transplantation conditioning
betibeglogene autotemcel
product surveillance, postmarketing
hematopoietic stem cell transplantation
aged
drug interactions
pregnancy
breast feeding
beta-Thalassemia
genetic therapy
transduction, genetic
hematopoietic stem cells
Betibeglogene Autotemcel
betibeglogene autotemcel
beta-Globins
---
https://www.has-sante.fr/jcms/p_3101051/fr/combo-stent
2019
France
health technology assessment
Monoclonal antibodies
antibodies, anti-idiotypic
stents
pharmacology
sirolimus
pharmacologist
antigens, CD34
extracellular matrix
antibodies, monoclonal
templates, genetic
monoclonal antibody
Monoclonal antibodies
---
Strimvelis - autologous CD34 enriched cell fraction that contains CD34 cells transduced
with retroviral vector that encodes for the human ADA cDNA sequence
https://www.ema.europa.eu/medicines/human/EPAR/Strimvelis
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
orphan drug production
severe combined immunodeficiency due to adenosine deaminase deficiency
severe combined immunodeficiency due to adenosine deaminase deficiency
gene therapy
Cell positive for CD34 antigen (cell)
Autologous Bone Marrow Transplantation
transplantation, autologous
infusions, intravenous
product surveillance, postmarketing
antigens, CD34
hematopoietic stem cell transplantation
drug evaluation, preclinical
genetic therapy
adenosine deaminase
adenosine deaminase
agammaglobulinemia
severe combined immunodeficiency
adenosine deaminase
agammaglobulinemia
severe combined immunodeficiency
---
